Point72 Middle East FZE’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-113,121	Closed	-$3.18M	–	777
2023 Q4	$3.18M	Buy	113,121 +73,602	+186%	+$2.07M	0.09%	123
2023 Q3	$1.07M	Buy	39,519 +1,460	+4%	+$39.6K	0.04%	280
2023 Q2	$1.17M	Buy	38,059 +12,016	+46%	+$369K	0.03%	278
2023 Q1	$938K	Buy	+26,043	New	+$938K	0.03%	253